Evidence map›Paper›PMID 31732771›Full record

Trial reportWorld journal of urology2020

Effect of active versus passive void trials on time to patient discharge, urinary tract infection, and urinary retention: a randomized clinical trial.

James T Mills, David E Rapp, Nathan M Shaw, Helen Y Hougen, Hannah E Agard, Robert M Case, Timothy L McMurry, Noah S Schenkman, Tracey L Krupski

2 registry-linked trialsAbstract readComparative StudyRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in World journal of urology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02886143 phase3completednot on this map

Effect of Active vs. Passive Voiding Trials on Time to Patient Discharge, Rate of Urinary Tract Infection, and Rate of Urinary Retention: a Randomized, Controlled Clinical Trial

TypeinterventionalSponsorUniversity of VirginiaRan2015 to 2016Enrolled274ConditionsUrinary Retention, Urinary Tract InfectionsArmsActive Voiding Trial, Passive Voiding Trial
NCT05885958 nacompletednot on this mapstarted 2023, after this paper: background citation

Timing of Active Void Trials After Urogynecologic Procedures

TypeinterventionalSponsorUniversity of South FloridaRan2023 to 2025Enrolled231ConditionsPostoperative Care, Urinary Catheters, UrogynecologyArmsTime
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

James T MillsDepartment of Urology, University of Virginia, P.O. Box 800422, Charlottesville, VA, 22908, USA.
David E RappDepartment of Urology, University of Virginia, P.O. Box 800422, Charlottesville, VA, 22908, USA. der4m@virginia.edu.ORCID http://orcid.org/0000-0002-8729-5301
Nathan M ShawDepartment of Urology, MedStar Health Georgetown University Hospital, Washington, DC, USA.
Helen Y HougenDepartment of Urology, Oregon Health and Science University, Portland, OR, USA.
Hannah E AgardDepartment of Urology, Cleveland Clinic Akron General, Akron, OH, USA.
Robert M CaseDepartment of Medicine, University of Florida, Gainesville, FL, USA.
Timothy L McMurryDepartment of Public Health Sciences, University of Virginia, Charlottesville, VA, USA.
Noah S SchenkmanDepartment of Urology, University of Virginia, P.O. Box 800422, Charlottesville, VA, 22908, USA.
Tracey L KrupskiDepartment of Urology, University of Virginia, P.O. Box 800422, Charlottesville, VA, 22908, USA.
University of Virginia · USCleveland Clinic · USGeorgetown University · USOregon Health & Science University · USUniversity of Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeWe sought to determine the effect of active versus passive voiding trials on time to hospital discharge and rates of urinary tract infection (UTI) and urinary retention (UR).

methodsWe performed a prospective, randomized trial comparing active (AVT) versus passive (PVT) void trials of inpatients requiring urethral catheter removal. Of 329 eligible patients, 274 were randomized to AVT (bladder filled with saline before catheter removal) or PVT (spontaneous bladder filling after catheter removal). Primary outcome was time to hospital discharge. Secondary outcomes were UTI (NSQIP criteria) and UR (requiring repeat catheterization) within 2 weeks of void trial.

resultsThe median time to void was 18 (5-115) versus 236 (136-360) min in the AVT and PVT groups, respectively (p < 0.0001). However, no difference was seen in comparison of the median time to hospital discharge between AVT [28.4 (13.6-69.3) h] and PVT [30.0 (10.4-75.6) h] cohorts, respectively (p = 0.93). Six (4.8%) and 13 (12.9%) patients developed UTI in the AVT and PVT groups, respectively (p = 0.03). Eleven (8.8%) and 12 (11.9%) patients developed UR in the AVT and PVT groups, respectively (p = 0.36).

conclusionOur study comparing AVT versus PVT demonstrated no difference in time to discharge despite a 3.6 h reduction in time to void associated with AVT. AVT was associated with a 63% reduction in UTI, with no difference seen in UR rates across cohorts. Given the reduction in UTI and technical advantages, our data suggest that AVT should be considered as a recommended technique for void trial protocol.

trial registrationNCT02886143 (clinicaltrials.gov).

Indexed as

Patient DischargeUrinationDevice RemovalFemaleHumansMaleMiddle AgedProspective StudiesTime FactorsUrinary CathetersUrinary RetentionUrinary Tract InfectionsDischargeUrinary retentionUrinary tract infectionVoid trial

Identifiers

PMID31732771
OpenAlexW2987496530

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.